Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, ARGAN INC insiders sold a net $87.6M of stock across 122 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Jun 18, 2026.
The trade is 48.8% of the 40,976 shares held after it.
5 other insiders sold within 30 days.
319 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Griffin William F Jr sold about $15.2M of AGX on Jun 22, 2026; 5 other insiders sold within 30 days and 319 funds added in the latest 13F quarter.
10 earlier Form 4 trades (code P or S) here by this insider (10 sales), the last on Jun 12, 2026.
The trade is 49.2% of the 60,976 shares held after it.
5 other insiders sold within 30 days.
319 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Griffin William F Jr sold about $21.8M of AGX on Jun 18, 2026; 5 other insiders sold within 30 days and 319 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Apr 16, 2026.
The trade is 25.5% of the 1,784 shares held after it.
5 other insiders sold within 30 days.
319 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Baugher Joshua Scott sold about $333.4K of AGX on Jun 17, 2026; 5 other insiders sold within 30 days and 319 funds added in the latest 13F quarter.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Apr 16, 2026.
The trade is 20.6% of the 1,479 shares held after it.
5 other insiders sold within 30 days.
319 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Baugher Joshua Scott sold about $223.9K of AGX on Jun 17, 2026; 5 other insiders sold within 30 days and 319 funds added in the latest 13F quarter.
122 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
AGX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
John Ronald Jeffrey Jr.
Filed 2026-07-31
$3.4M
Griffin William F Jr
Filed 2026-06-22
$15.3M
Griffin William F Jr
Filed 2026-06-18
$22.0M
AGX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
First Trust RBA American Industrial Renaissance ETF
$543.6M position · as of 2026-06-30
4.7%
Corgi Natural Gas Power & Turbines ETF
$519.9K position · as of 2026-06-30
4.3%
First Trust Small Cap BuyWrite Income ETF
$1.0M position · as of 2026-06-30
4.2%
Sit Small Cap Growth Fund
$5.8M position · as of 2026-06-30
4.0%
Sit Small Cap Dividend Growth Fund
$2.1M position · as of 2026-06-30
3.8%
Thornburg Focus Growth Fund
$7.9M position · as of 2026-06-30
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $87.6M sold by insiders over 180 days, 319 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $3.4M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.2B
four quarters, 2025-08-01 to 2026-07-31
Revenue, TTM AGX
FY Jan 2026
$944.6M
FY Jan 2025
$874.2M
FY Jan 2024
$573.3M
FY Jan 2023
$455.0M
FY Jan 2022
$509.4M
Jul 2026
$384.0M
Apr 2026
$291.0M
Jan 2026
$262.1M
Oct 2025
$251.2M
Jul 2025
$237.7M
Apr 2025
$193.7M
Jan 2025
$232.5M
Oct 2024
$257.0M
At each fiscal year end
Single quarter
Net margin, TTM
+15.1%
net income over revenue, 2025-08-01 to 2026-07-31
Net margin, TTM AGX
FY Jan 2026
+14.6%
FY Jan 2025
+9.8%
FY Jan 2024
+5.6%
FY Jan 2023
+7.6%
FY Jan 2022
+7.0%
Jul 2026
+13.9%
Apr 2026
+15.8%
Jan 2026
+18.8%
Oct 2025
+12.2%
Jul 2025
+14.8%
Apr 2025
+11.6%
Jan 2025
+13.5%
Oct 2024
+10.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$545.7M
operating cash flow minus capex, 2025-08-01 to 2026-07-31
Free cash flow, TTM AGX
FY Jan 2026
$410.8M
FY Jan 2025
$161.0M
FY Jan 2024
$114.1M
FY Jan 2023
-$33.4M
FY Jan 2022
$27.0M
Jul 2026
$91.7M
Apr 2026
$111.0M
Jan 2026
$171.1M
Oct 2025
$171.9M
Jul 2025
$32.9M
Apr 2025
$34.9M
Jan 2025
$43.3M
Oct 2024
$29.2M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity AGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt AGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+39.8%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on equity AGX
FY Jan 2026
+33.8%
FY Jan 2025
+26.6%
FY Jan 2024
+11.3%
FY Jan 2023
+11.4%
FY Jan 2022
+11.0%
Jul 2026
+39.8%
Apr 2026
+38.5%
Jan 2026
+33.8%
Oct 2025
+32.0%
Jul 2025
+33.4%
Apr 2025
+30.5%
Jan 2025
+26.6%
Oct 2024
+21.5%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+15.7%
TTM net income over average of 2025-07-31 and 2026-07-31
Return on assets AGX
FY Jan 2026
+13.6%
FY Jan 2025
+11.9%
FY Jan 2024
+5.9%
FY Jan 2023
+6.7%
FY Jan 2022
+6.2%
Jul 2026
+15.7%
Apr 2026
+15.5%
Jan 2026
+13.6%
Oct 2025
+13.2%
Jul 2025
+14.6%
Apr 2025
+14.1%
Jan 2025
+11.9%
Oct 2024
+9.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital AGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+39.6%
operating income (EBIT proxy) over average of 2025-07-31 and 2026-07-31 minus current liabilities
Return on capital employed AGX
FY Jan 2026
+32.4%
FY Jan 2025
+27.0%
FY Jan 2024
+12.5%
FY Jan 2023
+13.5%
FY Jan 2022
+13.5%
Jul 2026
+39.6%
Apr 2026
+36.2%
Jan 2026
+32.4%
Oct 2025
+31.3%
Jul 2025
+33.1%
Apr 2025
+31.8%
Jan 2025
+27.0%
Oct 2024
+21.6%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
26.98x
close 2026-10-27 over four quarters of diluted EPS, 2025-08-01 to 2026-07-31
P/E, trailing AGX
FY Jan 2026
35.64x
FY Jan 2025
22.32x
FY Jan 2024
18.55x
FY Jan 2023
16.73x
FY Jan 2022
15.41x
Jul 2026
45.13x
Apr 2026
58.87x
Jan 2026
35.64x
Oct 2025
35.98x
Jul 2025
29.37x
Apr 2025
21.42x
Jan 2025
22.32x
Oct 2024
27.62x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value AGX
FY Jan 2026
n/a
FY Jan 2025
n/a
FY Jan 2024
n/a
FY Jan 2023
n/a
FY Jan 2022
n/a
Jul 2026
n/a
Apr 2026
n/a
Jan 2026
n/a
Oct 2025
n/a
Jul 2025
n/a
Apr 2025
n/a
Jan 2025
n/a
Oct 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+11.4%
TTM free cash flow over market value at close 2026-10-27
FCF yield AGX
FY Jan 2026
+8.5%
FY Jan 2025
+8.7%
FY Jan 2024
+19.3%
FY Jan 2023
-6.3%
FY Jan 2022
+4.6%
Jul 2026
+6.8%
Apr 2026
+5.2%
Jan 2026
+8.5%
Oct 2025
+6.7%
Jul 2025
+4.2%
Apr 2025
+8.6%
Jan 2025
+8.7%
Oct 2024
+8.0%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.52x
P/E over trailing EPS growth of 52%: four quarters to 2026-07-31 against the four to 2025-07-31
PEG, trailing AGX
FY Jan 2026
0.61x
FY Jan 2025
0.14x
FY Jan 2024
7.20x
FY Jan 2023
n/a
FY Jan 2022
0.26x
Jul 2026
0.88x
Apr 2026
1.00x
Jan 2026
0.61x
Oct 2025
0.46x
Jul 2025
0.18x
Apr 2025
0.14x
Jan 2025
0.14x
Oct 2024
0.30x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AGX ranks highest on profitability (92nd percentile) and institutional and government (78th), and lowest on insider conviction (5th), among Construction peers.
Profitability
92
Inputs
Return on equity+39.8% · 91 pct, sector of 48
Return on assets+15.7% · 93 pct, sector of 56
Return on invested capitalno debt line filed
Return on capital employed+39.6% · 91 pct, sector of 36
Growth
33
Inputs
Revenue growth, YoY+8.1% · 51 pct, sector of 71
Backlog growth, YoY-29.3% · 15 pct, universe of 855
Insider conviction
5
Inputs
Net Form 4 buying (codes P and S), 180d-$87.6M · 10 pct, sector of 41
Insider buyers, 180d0 · 0 pct, sector of 42
Institutional and government
78
Inputs
Funds adding, latest quarter319 · 83 pct, sector of 54
Congress net buyers, 365d1 · 73 pct, universe of 718
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
18
Inputs
Short interest, % of float+7.8% · 34 pct, sector of 77
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+56.8% · 2 pct, sector of 51
2 not measured: Financial health, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
AGX filings, in plain words
Are Argan insiders buying or selling AGX?
In the 180 days to 2026-10-28, Argan insiders were net sellers, a net $87.6M across purchases and sales reported on Form 4, by 7 sellers.
Have members of Congress traded AGX?
Yes. In the year to 2026-10-28, 1 House member disclosed buying AGX and 0 House members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-06-30.
Are there planned insider sales of AGX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $3.4M of stock; the latest, by John Ronald Jeffrey Jr., was filed 2026-07-31.
Read the full summary
In the 180 days to 2026-10-28, Argan insiders were net sellers of AGX, a net $87.6M across purchases and sales reported on Form 4 by 7 sellers. None of the 12 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying AGX and 0 members disclosed selling it; the latest on record is a purchase by Gilbert Cisneros dated 2026-06-30. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $3.4M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.